GDF-8
Also known as: Myostatin, Growth Differentiation Factor 8
The natural myostatin protein - understanding it is key to muscle growth interventions.
Overview
GDF-8 (Myostatin) is a naturally occurring protein that inhibits muscle growth. While not typically administered as a therapeutic (inhibitors are used instead), understanding myostatin biology is crucial for developing muscle-building interventions. Myostatin inhibitors like follistatin and ACE-031 work by blocking GDF-8.
Mechanism of Action
Binds to activin type II receptors (ACVR2A/B) and signals through ALK4/5 to activate Smad2/3 pathway. Inhibits satellite cell proliferation and myoblast differentiation, limiting muscle growth.
Pharmacokinetics
Endogenous protein. When administered exogenously, variable half-life based on formulation.
Dosing Protocols
Note: These are research protocols from literature. This is not medical advice.
N/A
Not administered
N/A
N/A
Myostatin inhibitors are used therapeutically, not myostatin itself
Research Areas
Key Research Findings
- 1Natural inhibitor of muscle growth
- 2Knockout animals show massive muscle hypertrophy
- 3Target for therapeutic inhibition, not administration
- 4Myostatin inhibitors promote muscle growth
Side Effects & Contraindications
Reported Side Effects
- N/A
Contraindications
- Not for exogenous administration
Safety Considerations
Not administered therapeutically. Inhibitors of GDF-8 are used instead. Understanding for research purposes.
Storage Requirements
N/A
Scientific References
- 1